S. Sipahi Et Al. , "Omalizumab-induced erythema multiforme in a patient with chronic spontaneous urticaria," Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , vol.73, Munich, Germany, pp.688, 2018
Sipahi, S. Et Al. 2018. Omalizumab-induced erythema multiforme in a patient with chronic spontaneous urticaria. Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (Munich, Germany), 688.
Sipahi, S., Ozceker, D., Suleyman, A., Akcay, A., Guler, N., & Tamay, Z. Ü., (2018). Omalizumab-induced erythema multiforme in a patient with chronic spontaneous urticaria . Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.688). Munich, Germany
Sipahi, Sevgi Et Al. "Omalizumab-induced erythema multiforme in a patient with chronic spontaneous urticaria," Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Germany, 2018
Sipahi, Sevgi S. Et Al. "Omalizumab-induced erythema multiforme in a patient with chronic spontaneous urticaria." Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Munich, Germany, pp.688, 2018
Sipahi, S. Et Al. (2018) . "Omalizumab-induced erythema multiforme in a patient with chronic spontaneous urticaria." Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Munich, Germany, p.688.
@conferencepaper{conferencepaper, author={Sevgi SİPAHİ ÇİMEN Et Al. }, title={Omalizumab-induced erythema multiforme in a patient with chronic spontaneous urticaria}, congress name={Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={Munich}, country={Germany}, year={2018}, pages={688} }